COVID-19 (Corona virus disease of 2019) is the clinical presentation of acute disease associated with infection by the beta coronavirus SARSCoV-2. Centers across Europe and USA have recently been reporting a multi-system inflammatory syndrome affecting children (MIS-C) and young people (< 19 years), temporally associated with the SARS-CoV-2 pandemic, elevated serologic inflammatory markers and cytokine levels, in which major cardiovascular compromise is a key feature. Children are presenting with multi-system involvement with significant inflammation and resemble Kawasaki Disease. These patients manifested features of atypical Kawasaki disease together with cardiac inflammation overlapping with toxic shock syndrome and Kawasaki disease shock syndrome. This is most likely a post-infectious complication of infection with SARS-CoV-2. Our knowledge of this newly described entity is evolving by the day and this review summarizes the current available literature on case definition, clinical presentation, diagnosis and management of this syndrome. The pediatric and cardiology communities should be acutely aware of this new disease, probably related to SARS-CoV-2 infection. An early diagnosis and management appear to lead to favorable outcome using classical therapies.